China National Medicines Corporation Ltd. (SHA: 600511)

China flag China · Delayed Price · Currency is CNY
36.55
+2.16 (6.28%)
Nov 20, 2024, 3:00 PM CST
27.04%
Market Cap 27.58B
Revenue (ttm) 51.19B
Net Income (ttm) 2.16B
Shares Out 754.50M
EPS (ttm) 2.87
PE Ratio 12.74
Forward PE 11.44
Dividend 0.85 (2.48%)
Ex-Dividend Date Jun 13, 2024
Volume 20,893,260
Open 34.40
Previous Close 34.39
Day's Range 34.26 - 36.72
52-Week Range 27.12 - 38.00
Beta 0.45
Analysts n/a
Price Target n/a
Earnings Date Mar 21, 2025

About China National Medicines Corporation

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. [Read more]

Sector Healthcare
Founded 1999
Employees 3,138
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600511
Full Company Profile

Financial Performance

In 2023, China National Medicines Corporation's revenue was 49.70 billion, an increase of 9.23% compared to the previous year's 45.50 billion. Earnings were 2.15 billion, an increase of 9.26%.

Financial Statements

News

There is no news available yet.